Search

everythinglearnresearchcommunity

for

Search:↓

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

TRPV channels are important in osteoarthritis and could be key to new treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

AVT is highly conserved and may have antimicrobial properties.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Blocking certain brain processes reduces mating behavior in female rats.

Certain alkaloids could help create new coronavirus drugs.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.